Acute Hepatitis C Virus Infection Treated with Daclatasvir/Sofosbuvir in a 9-Year-Old Boy

Abstract The present study includes a case report of a 9-year-old boy who came to our center with jaundice, elevated liver enzymes, and palpable liver. He was treated with ursodeoxycholic acid, but no improvement in symptoms was seen. Reverse transcription polymerase chain reaction and liver biopsy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of child science 2022-01, Vol.12 (1), p.e79-e82
Hauptverfasser: Rahmani, Parisa, Farahmand, Fatemeh, Heidari, Ghobad
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e82
container_issue 1
container_start_page e79
container_title Journal of child science
container_volume 12
creator Rahmani, Parisa
Farahmand, Fatemeh
Heidari, Ghobad
description Abstract The present study includes a case report of a 9-year-old boy who came to our center with jaundice, elevated liver enzymes, and palpable liver. He was treated with ursodeoxycholic acid, but no improvement in symptoms was seen. Reverse transcription polymerase chain reaction and liver biopsy were positive for hepatitis C virus. He was treated with daclatasvir/sofosbuvir for 3 months. Daclatasvir/sofosbuvir might be effective against the treatment of hepatitis in children, with no report of remission and minimal side effects.
doi_str_mv 10.1055/s-0042-1751269
format Article
fullrecord <record><control><sourceid>thieme_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1055_s_0042_1751269</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1055_s_0042_1751269</sourcerecordid><originalsourceid>FETCH-LOGICAL-c202t-8c3ce0e06935cf3d2765d04b163fb4fd63ba56fb18d5191363a9836acc0384933</originalsourceid><addsrcrecordid>eNp1kD1vwjAYhK2qlYooa2f_AcNrO3aSkdIPkJAYSisxWY5jCyNIkO204t83CAaWTnfD3en0IPRMYUxBiEkkABkjNBeUyfIODViWZ0QUOb2_8Y9oFOMOAGhJJWN8gDZT0yWL5_aok08-4hn-9qGLeNE4a5JvG7wOVidb41-ftvhVm71OOv74MPlsXRurrrfYN1jjkmysDmS1r_FLe3pCD07vox1ddYi-3t_WszlZrj4Ws-mSGAYskcJwY8GCLLkwjtcsl6KGrKKSuypzteSVFtJVtKhF_5pLrsuCS20M8CIrOR-i8WXXhDbGYJ06Bn_Q4aQoqDMbFdWZjbqy6QvkUkhbbw9W7douNP3D__J_lKJjzg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Acute Hepatitis C Virus Infection Treated with Daclatasvir/Sofosbuvir in a 9-Year-Old Boy</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Thieme Connect Journals Open Access</source><creator>Rahmani, Parisa ; Farahmand, Fatemeh ; Heidari, Ghobad</creator><creatorcontrib>Rahmani, Parisa ; Farahmand, Fatemeh ; Heidari, Ghobad</creatorcontrib><description>Abstract The present study includes a case report of a 9-year-old boy who came to our center with jaundice, elevated liver enzymes, and palpable liver. He was treated with ursodeoxycholic acid, but no improvement in symptoms was seen. Reverse transcription polymerase chain reaction and liver biopsy were positive for hepatitis C virus. He was treated with daclatasvir/sofosbuvir for 3 months. Daclatasvir/sofosbuvir might be effective against the treatment of hepatitis in children, with no report of remission and minimal side effects.</description><identifier>ISSN: 2474-5871</identifier><identifier>EISSN: 2474-5871</identifier><identifier>DOI: 10.1055/s-0042-1751269</identifier><language>eng</language><publisher>Rüdigerstraße 14, 70469 Stuttgart, Germany: Georg Thieme Verlag KG</publisher><subject>Case Report</subject><ispartof>Journal of child science, 2022-01, Vol.12 (1), p.e79-e82</ispartof><rights>The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c202t-8c3ce0e06935cf3d2765d04b163fb4fd63ba56fb18d5191363a9836acc0384933</cites><orcidid>0000-0002-6490-4127</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0042-1751269.pdf$$EPDF$$P50$$Gthieme$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.thieme-connect.de/products/ejournals/html/10.1055/s-0042-1751269$$EHTML$$P50$$Gthieme$$Hfree_for_read</linktohtml><link.rule.ids>314,778,782,20878,27911,27912,54574,54602</link.rule.ids></links><search><creatorcontrib>Rahmani, Parisa</creatorcontrib><creatorcontrib>Farahmand, Fatemeh</creatorcontrib><creatorcontrib>Heidari, Ghobad</creatorcontrib><title>Acute Hepatitis C Virus Infection Treated with Daclatasvir/Sofosbuvir in a 9-Year-Old Boy</title><title>Journal of child science</title><description>Abstract The present study includes a case report of a 9-year-old boy who came to our center with jaundice, elevated liver enzymes, and palpable liver. He was treated with ursodeoxycholic acid, but no improvement in symptoms was seen. Reverse transcription polymerase chain reaction and liver biopsy were positive for hepatitis C virus. He was treated with daclatasvir/sofosbuvir for 3 months. Daclatasvir/sofosbuvir might be effective against the treatment of hepatitis in children, with no report of remission and minimal side effects.</description><subject>Case Report</subject><issn>2474-5871</issn><issn>2474-5871</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>0U6</sourceid><recordid>eNp1kD1vwjAYhK2qlYooa2f_AcNrO3aSkdIPkJAYSisxWY5jCyNIkO204t83CAaWTnfD3en0IPRMYUxBiEkkABkjNBeUyfIODViWZ0QUOb2_8Y9oFOMOAGhJJWN8gDZT0yWL5_aok08-4hn-9qGLeNE4a5JvG7wOVidb41-ftvhVm71OOv74MPlsXRurrrfYN1jjkmysDmS1r_FLe3pCD07vox1ddYi-3t_WszlZrj4Ws-mSGAYskcJwY8GCLLkwjtcsl6KGrKKSuypzteSVFtJVtKhF_5pLrsuCS20M8CIrOR-i8WXXhDbGYJ06Bn_Q4aQoqDMbFdWZjbqy6QvkUkhbbw9W7douNP3D__J_lKJjzg</recordid><startdate>202201</startdate><enddate>202201</enddate><creator>Rahmani, Parisa</creator><creator>Farahmand, Fatemeh</creator><creator>Heidari, Ghobad</creator><general>Georg Thieme Verlag KG</general><scope>0U6</scope><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-6490-4127</orcidid></search><sort><creationdate>202201</creationdate><title>Acute Hepatitis C Virus Infection Treated with Daclatasvir/Sofosbuvir in a 9-Year-Old Boy</title><author>Rahmani, Parisa ; Farahmand, Fatemeh ; Heidari, Ghobad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c202t-8c3ce0e06935cf3d2765d04b163fb4fd63ba56fb18d5191363a9836acc0384933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Case Report</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rahmani, Parisa</creatorcontrib><creatorcontrib>Farahmand, Fatemeh</creatorcontrib><creatorcontrib>Heidari, Ghobad</creatorcontrib><collection>Thieme Connect Journals Open Access</collection><collection>CrossRef</collection><jtitle>Journal of child science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rahmani, Parisa</au><au>Farahmand, Fatemeh</au><au>Heidari, Ghobad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acute Hepatitis C Virus Infection Treated with Daclatasvir/Sofosbuvir in a 9-Year-Old Boy</atitle><jtitle>Journal of child science</jtitle><date>2022-01</date><risdate>2022</risdate><volume>12</volume><issue>1</issue><spage>e79</spage><epage>e82</epage><pages>e79-e82</pages><issn>2474-5871</issn><eissn>2474-5871</eissn><abstract>Abstract The present study includes a case report of a 9-year-old boy who came to our center with jaundice, elevated liver enzymes, and palpable liver. He was treated with ursodeoxycholic acid, but no improvement in symptoms was seen. Reverse transcription polymerase chain reaction and liver biopsy were positive for hepatitis C virus. He was treated with daclatasvir/sofosbuvir for 3 months. Daclatasvir/sofosbuvir might be effective against the treatment of hepatitis in children, with no report of remission and minimal side effects.</abstract><cop>Rüdigerstraße 14, 70469 Stuttgart, Germany</cop><pub>Georg Thieme Verlag KG</pub><doi>10.1055/s-0042-1751269</doi><orcidid>https://orcid.org/0000-0002-6490-4127</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2474-5871
ispartof Journal of child science, 2022-01, Vol.12 (1), p.e79-e82
issn 2474-5871
2474-5871
language eng
recordid cdi_crossref_primary_10_1055_s_0042_1751269
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Thieme Connect Journals Open Access
subjects Case Report
title Acute Hepatitis C Virus Infection Treated with Daclatasvir/Sofosbuvir in a 9-Year-Old Boy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T12%3A36%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-thieme_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acute%20Hepatitis%20C%20Virus%20Infection%20Treated%20with%20Daclatasvir/Sofosbuvir%20in%20a%209-Year-Old%20Boy&rft.jtitle=Journal%20of%20child%20science&rft.au=Rahmani,%20Parisa&rft.date=2022-01&rft.volume=12&rft.issue=1&rft.spage=e79&rft.epage=e82&rft.pages=e79-e82&rft.issn=2474-5871&rft.eissn=2474-5871&rft_id=info:doi/10.1055/s-0042-1751269&rft_dat=%3Cthieme_cross%3E10_1055_s_0042_1751269%3C/thieme_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true